GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, has announced that it has raised US$45 million in a Series C financing led by Gilde Healthcare Partners with participation from existing institutional investors MVM Partners, MedTech Venture Partners, and BlueStone Venture Partners.
Latham & Watkins LLP represented GT Medical Technologies in the financing with a corporate team led by Bay Area partner Luke Bergstrom, with associates Omar Ammash, Erica Kucharski, Autumn Schmidt, and Jude Baldo. Advice was also provided on tax and benefits & compensation matters by Bay Area partner Ashley Wagner.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
